At £699 / $699, the new Arcam CD5 could be hitting a sweet spot in a price range that has long gathered dust, just like many an audiophile’s CD collection. And if its amplifier siblings’ performances ...

Vittoria Biotherapeutics, a clinical-stage immunotherapy company specializing in the development of innovative cell therapies ...

PHILADELPHIA, PA — Vittoria Biotherapeutics will present groundbreaking research on its innovative Senza5™ platform at the 66th American Society of Hematology (ASH) Annual Meeting in San Diego, CA, ...

Nov. 22, 2024 — Geneticists have developed a gene drive-based solution to the widespread problem of insecticide resistance. In an effort to protect valuable crops, the researchers created an 'e ...

VIPER-101 leverages the company’s proprietary Senza5 TM platform technology, which enhances T cell effector function by abrogating CD5-mediated immunosuppression through gene editing.

Gene expression is the generation of a functional gene product from the information encoded by a gene, through the processes of transcription and translation. Gene products are often proteins ...

could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for CD5, a protein found on the surface of T cells, according to a ... Oct. 17, 2024 — Researchers discovered they ...

Gene therapy involves the introduction of new genes into cells, to restore or add gene expression, for the purpose of treating disease. Most commonly a mutated gene is replaced with DNA encoding a ...

The company, which secured $200 million from investors in a private funding deal last week, learned Tuesday of a serious side effect experienced by one participant on a high dose of its Rett therapy.